What kind of expertise do you need?


ExpertsIn business, people fuel success
Zac Stillerman
Zac Stillerman
President and General Manager
Committed to ensuring that patients get the right medicine at the right time so they can thrive—and guiding clients as they rise to this challenge. Deep understanding of the US healthcare provider market developed through decades of experience, including expertise in core system optimization, clinical operations, value-based care, physician practice management, financial reporting, and revenue cycle.
J. Bruce Leavitt
J. Bruce Leavitt, MBA
Executive Vice President, Managing Partner
Innovator of novel promotional effectiveness measures, insight-driven analysis methodologies, and dynamic CRM-based tools and applications for account management and pull-through. Expert in solving market access challenges for pharma across market channels, therapeutic classes, and routes of administration.
Larry Blandford
Larry Blandford, PharmD
Executive Vice President, Managing Partner
Industry leader in market insights, medication management, and access strategy for pharmaceuticals. Combines deep payer experience and insights across the market access landscape to drive strategic planning and guide execution.
Carolyn Harley
Carolyn Harley, PhD, MPA
Senior Vice President and General Manager, PHE
Strategic leader directing a team of economists, statisticians, modelers, and research scientists while establishing strategic direction for operations and organizational growth. Dr. Harley has broad experience in research, market access, business development, and client relationship management.
Kathy Lang
Kathy Lang, PhD
Vice President, HEOR and RWE
Long-standing HEOR leader, advising clients in the life sciences industry on real-world evidence strategy and execution studies. Expert in statistical/econometric methods and leveraging primary and secondary data. Authority across a wide array of therapeutic areas and study designs, including clinical trials, model-based cost-effectiveness and budget impact analyses, trial-based economic evaluations, retrospective database studies, meta-analyses, enriched retrospective and observational studies, and software tool development for field-based teams. Widely published in peer-review journals on a range HEOR topics.
Ashwin Athri
Ashwin Athri, MBA
Senior Vice President, Promotional Effectiveness
Technology innovator, charged with advancing data analytics through the development and implementation of novel technology solutions. Specialized knowledge of prescriber targeting, opportunity analysis, database design and development, payer value proposition creation, pricing, and Rx-to-over-the-counter (OTC) forecast models.
Maria Lorenzi
Maria Lorenzi
Director, Evidence Synthesis and Decision Modeling
Respected biostatistician, widely published author and leading expert in literature reviews and network meta-analyses, including complex and non-standard Bayesian network meta-analyses. Strategic focus on oncology, diabetes, rheumatology and immunology. Extends insights through custom-developed code (R functions and packages) to improve data preparation and synthesis of raw results for presentation.
Alexander Grosvenor
Alexander Grosvenor
Vice President, Global Pricing and Product Strategy
Wide-ranging expert in global pricing and market access, with specific knowledge of European markets and the disciplines of launch sequencing, cross-indication pricing, international price referencing, and global launch pricing. Specialized focus in orphan indications and cell and gene therapies, backed by extensive knowledge of oncology, cardiovascular disease, central nervous system diseases, human immunodeficiency virus, and multiple sclerosis.
Naina Ahmad
Naina Ahmad
Senior Vice President, Managing Director, Insight Strategy Advisors
Biological and biomedical science veteran with expertise covering the entire product life cycle, including managed care strategy, global market access optimization, pricing and contracting strategies (both traditional and innovative), and international healthcare policy. Leader of numerous multidisciplinary global teams in support of pharmaceutical, biotech, medical device, and molecular diagnostics innovators.
Aaron Salamon
Aaron Salamon, MBA
Senior Director, Business Intelligence
Expert in payer and commercial analytics with a unique ability to bridge disparate payer data to derive actionable insights. Deep understanding of the structures and functions of managed markets organizations across the pharmaceutical industry. Straddles the cutting edge of technological and environmental changes in healthcare.
Shannon Cope
Shannon Cope, MSc
Director, Evidence Synthesis and Decision Modeling
Seasoned research scientist specializing in evidence strategy and decision modeling, leading teams that are focused on oncology, cardiovascular diseases, respiratory diseases, diabetic macular edema, Crohn’s and ulcerative colitis and epilepsy. Widely published author of papers in peer-reviewed journals on both sides of the Atlantic.
Craig White
Craig White, PhD
Vice President, Managing Director, Evidence Synthesis and Decision Modeling
Industry-leading strategic expert with focus on precommercial strategy, commercial strategy, launch strategy, salesforce targeting, alignment and messaging. Specialist in value-based pricing, outcomes-based contracting and use of real-world data and analytics, bolstered by a unique blend of business and technology expertise. Has developed and commercialized multiple large-scale US healthcare datasets.
Marie Davenport
Marie Davenport
Director, Business Intelligence
Expert in data integration and key drivers impacting pharmaceutical product uptake. Leader of managed markets initiatives, from requirements gathering, data structure design and development, test case creation and execution, and ongoing updates, modifications, and delivery of monthly refreshes. Develops custom analytic tools to meet specific client needs.
Naomi Sacks
Naomi Sacks, PhD
Director, Evidence Strategy, Generation and Communication
Health policy expert and leading researcher into real-world evidence, delivering scientifically rigorous and commercially relevant research to global biopharmaceutical companies. Specialized knowledge of acute myocardial infarction hospitalizations and outcomes, as well as diabetes, osteoarthritis and broader heart disease issues. Academician, peer reviewer for seven respected journals, and frequent contributor to leading medical journals.
David Kaplan
David Kaplan, RPh
Senior Vice President, Promotional Effectiveness
Results-driven pharmaceutical marketer and market research leader, with a history of developing and executing innovative approaches to the understanding of global and US payer customers and healthcare systems, developing value-based pricing across dozens of brands. Thought leader in business analysis, pricing and contracting, modeling and strategy development.
Eric Daugherty
Eric Daugherty, MBA
Senior Vice President, Promotional Effectiveness
Long-standing leader in biopharmaceutical access and managed markets strategies, with expertise spanning strategic pricing and health outcomes, pull-through messaging, salesforce performance reports, business-to-business brand management, disease management, and account management. Specialized insight into the specifics of mental health provider networks.
Greg Berzolla
Greg Berzolla, MBA
Senior Vice President, Business Analytics and Promotional Effectiveness
Payer industry veteran specializing in pharmacy benefits management, organizational design, and operational improvement projects spanning claims processing, customer service, membership accounting, and clinical services. Expert in Medicare Star ratings measurement and improvement for prescription drug plans and Medicare Advantage plans, spanning clinical and operational areas.
Harry Grant Schiavi
Harry Grant Schiavi
Managing Partner, Insight Strategy Advisors
Industry expert and advisor with 28+ years of experience in the pharmaceutical and biotechnology industry, with particular emphasis on market access, pricing and reimbursement. Specialized focus on evaluating and quantifying market access risks associated with both innovative and undifferentiated products as well as the intricacies and complexities of market access contracting and negotiation.
Ivar Jensen
Ivar Jensen, MBA
Director, Evidence Strategy, Generation and Communication
Veteran health economist focused on developing rigorous and commercially relevant BIMs, cost calculators, and other health economic models for life sciences companies. Expert in the development of health economic models, HEOR value messages, commercial assessments, merger and acquisition support, asset valuation, and competitive analysis across many therapeutic areas.
Jay Jauregui
Jay Jauregui
Senior Vice President, Managing Director, Insight Strategy Advisors
Accomplished management consultant with an emphasis in biotechnology, pharmaceuticals, medical devices, and consumer products. 150+ biotech and pharmaceutical engagements, including the development of market access and reimbursement strategies, payer value propositions, and pricing and contracting analyses, as well as specialty distribution strategies for small molecules, biologics, and orphan products. Expertise in a wide range of therapeutic areas and drug classes, including specialty, orphan, oncology, and traditional products.
Jeroen Jansen
Jeroen Jansen, PhD, MSc
Vice President, Chief Scientist, Evidence Synthesis and Decision Modeling
Recognized expert in evidence synthesis and decision modeling for value assessment of medical interventions. Adjunct Professor of Health Research & Policy (Epidemiology) at Stanford University, co-author of a textbook on network meta-analysis, and widely published on applied and methods research in his areas of expertise. Lead Scientific Advisor of the Open Source Value Project (OSVP) at the Innovation and Value Initiative (IVI).
Mridul Malhotra
Mridul Malhotra, MPH
Senior Vice President, Managing Director, Global Pricing and Product Strategy
Operational and strategic expert trusted by prescribers, hospitals administrators, and pharmaceutical and biotech executives. Developer of key global pricing and market access strategies that articulate clinical evidence to substantiate value for top biopharma and medical device products. Expertise spans all aspects of strategic business planning, including burden of disease and landscape assessments, global value propositions and value stories, revenue forecasting, licensing assessments, cost-effectiveness/budget impact modeling, and dossier development.
Phil Cyr
Phil Cyr, MPH
Vice President, Evidence Strategy, Generation and Communication
HEOR industry veteran with experience spanning health economics and health policy research, health technology assessment and payer experience, and a strong record of conducting published, peer-reviewed research. Leader in the development and execution of academically rigorous and commercially relevant HEOR studies. Peer reviewer for the American Journal of Managed Care.
Sam Keeping
Sam Keeping
Director, Evidence Synthesis and Decision Modeling
Experienced health economist who specializes in integrating comparative effectiveness results into economic models. Has helped produce submissions to regulatory and health technology assessment agencies across the globe in a range of therapeutic areas, including oncology, ophthalmology, neurology, and infectious disease.
Steve Carter
Steve Carter
Senior Vice President, Global Pricing and Product Strategy
Industry expert focused on pricing and market access, opportunity valuation, product launch, channel strategy, customer segmentation, contracting, and competitive gaming. Sought-after author of articles and industry briefs, and presenter at international conferences on topics ranging from payer value proposition and pricing to the impact of healthcare reform.
Steve Kanters
Steve Kanters, PhD(c), MSc
Director of Health Analytics, Evidence Synthesis and Decision Modeling
World expert in network meta-analyses, health technology submissions, and global health research, focused on clinical and epidemiologic research. Innovator in network meta-analyses, harnessing the methodology for an FDA submission and for the World Health Organization to inform their HIV and HCV clinical and operational guidelines, both firsts. Author of over 50 peer-reviewed publications.
Brett DiNatale
Brett DiNatale, PhD
Director, Data Analytics Group
Seasoned veteran with over 15 years of experience analyzing healthcare data to quantify and model market dynamics. Focused on utilizing the diverse range of data available to address clients' business questions and to optimize their strategies. Expertise with market access and longitudinal patient data sources, advanced methodologies including predictive modeling and machine learning, and systems and solution architecture and deployment.
Supriya Saraf
Supriya Saraf
Director, Global Pricing and Product Strategy
Expert consultant with extensive experience in global pricing and market access engagements, including early P&MA strategy and clinical trial design input, product value proposition development and communication, launch pricing strategy and IPR risk assessment, and negotiation strategy and planning. Experience across a number of therapy areas including orphan diseases, cardiovascular disease, oncology, respiratory and neurology, with specific expertise in the orphan disease space.
Jason Shafrin
Jason Shafrin, PhD
Senior Director, Policy & Economics
Dr. Shafrin is an expert in value-based purchasing methods, quality of care measures, discrete choice experiment survey design, health insurance claims data analysis, and digital medicine. Dr. Shafrin has not only developed reports to advise government agencies such as the Institute of Medicine and Centers for Medicare and Medicaid Services (CMS), but his research has also been published in leading journals of economics, medicine, and health policy, including the Journal of the American Medical Association, Health Affairs, Health Economics, and Health Services Research. Prior to joining PHE, Dr. Shafrin served as a policy lead for Acumen, LLC. In this role, Dr. Shafrin helped CMS implement a number of provisions of the Affordable Care Act, including the design of value-based purchasing programs for hospitals, physicians, and home health agencies. Dr. Shafrin is also the Director of Research at the Innovation and Value Initiative.
Contact us
Discover exactly what Precision can do for you. We look forward to learning about your needs, exploring how we can support you, and sharing our proven approaches. For information and inquiries, please contact:
Zac Stillerman
Zac Stillerman
President and General Manager
phone-icon +1 240.316.3451
Larry Blandford
Larry Blandford, PharmD
Executive Vice President and Managing Partner
phone-icon +1 212.686.2650
J. Bruce Leavitt
J. Bruce Leavitt, MBA
Executive Vice President and Managing Partner
phone-icon +1 203.487.5240
Ross Maclean
Ross Maclean, MD, PHD, MBA
Senior Vice President and Head of Medical Affairs
phone-icon +1 310.984.7708
Harry Grant Schiavi
Harry Grant Schiavi
Managing Partner, Insight Strategy Advisors
phone-icon +1 302.379.1702
arrow-top